Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction

Nan Xiao1, Xiao-Long Li1, Xiao-Dong Zhu1

  • 1Department of Liver Surgery and Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, 117948Fudan University, Shanghai, China.

Surgical Innovation
|May 17, 2021
PubMed

Insights

Portal venous pressure gradient (PVPG) increases after liver resection predict post-hepatectomy liver failure (PHLF) in Child-Pugh A patients. Monitoring PVPG during surgery can identify high-risk individuals for PHLF.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Physiology
  • Liver Transplantation

Background:

  • Post-hepatectomy liver failure (PHLF) is a significant cause of mortality and morbidity following liver resection.
  • The suitability of Child-Pugh A patients with varying degrees of cirrhosis for hepatectomy remains a subject of debate.
  • Understanding intraoperative factors influencing PHLF is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the impact of portal venous pressure gradient (PVPG) variations during hepatectomy on the incidence of PHLF.
  • To identify predictive markers for PHLF in Child-Pugh A patients undergoing liver resection.

Main Methods:

  • PVPG was measured before and after liver resection in 60 Child-Pugh A patients.
  • Receiver operating characteristic (ROC) curve analysis determined the optimal PVPG cutoff for PHLF prediction.
  • Univariate and multivariable analyses identified independent risk factors for PHLF.

Main Results:

  • The mean PVPG increased from 5.17 ± 4.78 mmHg to 6.37 ± 4.44 mmHg post-resection.
  • An increment of 1.5 mmHg in PVPG was the optimal cutoff to predict PHLF.
  • Prothrombin time (PT), PVPG increments ≥ 1.5 mmHg, and resection of ≥ 3 liver segments were independent predictors of PHLF.

Conclusions:

  • An acute increase in PVPG after hepatectomy is associated with an elevated risk of PHLF in Child-Pugh A patients.
  • Intraoperative PVPG monitoring can aid in risk stratification for PHLF.
  • These findings may inform surgical decision-making and patient management.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
46
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
3.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
55
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
209